Only 7% of people with pancreatic cancer survive more than five years. New research from Cardiff University is helping to expand the knowledge of this form of cancer, with the hopes of informing developments of new treatments.
Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments.
Cholangiocarcinoma is a rare disease, with only two percent of patients with metastatic disease surviving past five years. But new funding is helping Cardiff University researchers to find out crucial information about this form of cancer.